PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION
ZP8396-25077
Phase 1 other active
Quick answer
PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION for Healthy / hepatic impaired volunteers only study to assess PK parameters is a Phase 1 program (other) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zealand Pharma A/S
- Indication
- Healthy / hepatic impaired volunteers only study to assess PK parameters
- Phase
- Phase 1
- Modality
- other
- Status
- active